Potent, selective GABAB
receptor antagonist (IC50
= 85 nM).
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Sold with the permission of Novartis Pharma AG
GABAB receptors as potential targets for drugs able to prevent excessive excitatory amino acid transmission in the spinal cord.
Bonanno et al.
Blockade of GABAB receptors facilitates muscarinic agonist-induced epileptiform activity in immature rat piriform cortex in vitro.
Libri et al.
Naunyn Schmiedebergs Arch.Pharmacol., 1998;358:168
CGP 52432: a novel potent and selective GABAB autoreceptor antagonist in rat cerebral cortex.
Lanza et al.
Potent, orally active GABAB receptor antagonists.
Froestl et al.
The citations listed below are publications that use Tocris products. Selected citations for CGP 52432 include:
Showing Results 1 - 10 of 14